later-line therapy innovations in mcrc
Published 5 years ago • 45 plays • Length 7:36Download video MP4
Download video MP3
Similar videos
-
5:56
future directions for later-line therapy in r/r mcrc
-
2:13
later-line treatment for mcrc: regorafenib or tas-102?
-
3:20
third-line and later-line therapies in r/r mcrc
-
7:31
deciding second-line treatment for mcrc
-
10:40
later lines of therapy for mcrc
-
6:37
management of r/r mcrc: sequencing for later-line therapies
-
7:30
second-line treatment for mcrc
-
25:06
colorectal cancer: sequencing and therapeutic approaches in first- and next-line treatment
-
2:23
metastatic colorectal cancer to the lungs
-
2:25
cancer cell biology: mutated kras & reciprocal signalling
-
3:11
mcrc: third-line treatment decisions
-
18:55
emerging treatment options for mcrc patients in the late-line setting
-
7:35
treatment options for third-line therapy in mcrc
-
5:29
changing realities in treating mcrc
-
3:18
conversion from unresectable to resectable mcrc in real-world patients
-
2:07
additional considerations for targeted therapy in mcrc
-
6:44
deciding on upfront treatment for mcrc
-
7:15
salvage therapy options for mcrc
-
1:09
dr. overman on second-line therapy options for colorectal cancer
-
3:39
mcrc: second-line treatment decisions
-
5:02
third-line treatment options for mcrc
-
4:16
second-line therapy for ras wild-type mcrc